Results 281 to 290 of about 1,774,216 (319)

Bilateral breast lymphoma in lactating woman: rare and particularly aggressive entity. [PDF]

Oxf Med Case Reports
Lahlimi FE, Abakarim O, Mhirig I, Tazi I.   +3 more
europepmc   +1 more source

3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline

Advanced Healthcare Materials, EarlyView.
Minimal residual disease (MRD) leads to cancer relapse and poor survival in ovarian cancer. The lack of representative 3D models limits therapy development. The microfluidics‐based high throughput 3D microtumor platform described here generates clinically‐relevant MRD models. The 3D microtumors recapitulate the molecular signatures of MRD from patients.
Xingyun Yang, Mara Artibani, Yongcheng Jin, Aneesh Aggarwal, Yujia Zhang, Sandra Muñoz‐Galvan, Ellina Mikhailova, Lena Rai, Nobina Mukherjee, Ravinash Krishna Kumar, Ashwag Albukhari, Shaohua Ma, Linna Zhou, Ahmed Ashour Ahmed, Hagan Bayley   +14 more
wiley   +1 more source

DNA methylation-predicted plasma protein levels and breast cancer risk. [PDF]

Breast Cancer Res
Kresovich JK, Reid BM, O'Brien KM, Xu Z, Byrd DA, Weinberg CR, Sandler DP, Taylor JA.   +7 more
europepmc   +1 more source

A Novel 3D High‐Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer

Advanced Healthcare Materials, EarlyView.
Ovarian cancer's high recurrence and therapy resistance demand new strategies. A high‐throughput drug screening pipeline using 3D spheroids, which showed poor concordance with 2D models, identified rapamycin as a promising candidate. In combination with cisplatin, rapamycin demonstrated significant in vitro and in vivo efficacy, highlighting the ...
Nazanin Karimnia, Amy L. Wilson, Brittany R. Doran, Jennie Do, Amelia Matthews, Gwo Y. Ho, Magdalena Plebanski, Thomas W. Jobling, Andrew N. Stephens, Maree Bilandzic   +9 more
wiley   +1 more source

Multi-omics insights into the roles of CCNB1, PLK1, and HPSE in breast cancer progression: implications for prognosis and immunotherapy. [PDF]

Discov Oncol
Su Q, Fang L, Li C, Yue L, Yun Z, Zhang H, Liu Q, Ma R, Zhong P, Liu H, Lou Z, Chen Z, Tan Y, Hao X, Wu C.   +14 more
europepmc   +1 more source

Trends and survival benefits of bilateral breast-conserving surgery in patients with metachronous bilateral breast cancer. [PDF]

BMC Womens Health
Huang Q, Lin Q, Yang Y.
europepmc   +1 more source

Molecule subtypes play important roles for second primary malignancies development based on 324,661 breast cancer survivors. [PDF]

Sci Rep
Shi J, Liu J, Tian G, Li D, Liang D, He Y.   +5 more
europepmc   +1 more source

Cell Progression and Survival Functions of Enzymes Secreted in Extracellular Vesicles Associated with Breast and Prostate Cancers. [PDF]

Cells
Onyiba CI, Kumar NK, Scarlett CJ, Weidenhofer J.   +3 more
europepmc   +1 more source

Clinical Application of Artificial Intelligence in Breast MRI. [PDF]

J Korean Soc Radiol
Kim JM, Ha SM.
europepmc   +1 more source

Breast imaging characteristics in Thai transgender women: mammography and ultrasound outcomes in a pilot study. [PDF]

Ther Adv Med Oncol
Suwajo P, Annoppornchai P, Prueksadee J, Krongtham P, Manasnayakorn S.   +4 more
europepmc   +1 more source